Does JenaValve’s New Designation Signal the Start of Another Strong Year for TAVR?
JenaValve is showing significant progress in the plan to get its transcatheter aortic valve replacement (TAVR) system approved. FDA granted the Irvine, CA-based company Breakthrough Device Designation for the JenaValve Pericardial TAVR system.
Читать дальше...